{
  "Q0": "Whole Exome Sequencing (WES)",
  "Q1": "Not specified",
  "Q2": "Yes",
  "Q3": "No",
  "Q4": "No",
  "Q5": "No",
  "Q6": "No",
  "Q7": "No",
  "Q8": "Yes",
  "Q8.1": "Targeted genetic testing for specific neurological conditions",
  "Q9": "Yes",
  "Q9.1": "No",
  "Q10": "No",
  "Q10.1": "Diagnostic",
  "Q11": "Yes",
  "Q12": "No",
  "Q13": "Not specified",
  "Q14": "Not listed",
  "Q15": "No",
  "Q16": "No",
  "Q17": "The policy requires that prior to WES, the patient should complete conventional diagnostic studies, have a definitive diagnosis that remains uncertain, and meet disease-specific criteria. The provider should document medical necessity showing the test will directly impact treatment, and the patient should have clinical features of a suspected inheritable condition or be at direct risk of inheriting a mutation.",
  "match": false
}